Rosiglitazone is effective and well tolerated in patients ≥65 years with type 2 diabetes

被引：0
|
作者：
Beebe, K
Patel, J
机构：
来源：
DIABETES | 1999年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0479
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [1] Rosiglitazone is effective and well tolerated in patients ≥65 years with type 2 diabetes.
    Beebe, KL
    DIABETOLOGIA, 1999, 42 : A227 - A227
  • [2] Rosiglitazone in combination with glibenclamide plus metformin is effective and well tolerated in Type 2 diabetes patients
    Jones, N
    Jones, T
    Menci, L
    Xu, J
    Freed, M
    Kreider, M
    DIABETOLOGIA, 2001, 44 : A235 - A235
  • [3] Rosiglitazone is effective and well tolerated as monotherapy in African Americans with type 2 diabetes
    Osei, K
    Miller, EE
    Everitt, DE
    Ilgenfritz, J
    Porter, LE
    Freed, MI
    DIABETES, 2001, 50 : A127 - A128
  • [4] Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes
    Rosak, C.
    Standl, E.
    Reblin, T.
    Stammer, H.
    Seidel, D. K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (09) : 1040 - 1047
  • [5] Lixisenatide is effective and well tolerated in patients with type 2 diabetes mellitus and renal impairment
    Hanefeld, M.
    Ambos, A.
    Arteaga, J.
    Leiter, L. A.
    Marchesini, G.
    Nikonova, E.
    Shestakova, M.
    Stager, W.
    Tambascia, M.
    Gomez Huelgas, R.
    DIABETOLOGIA, 2014, 57 : S341 - S342
  • [6] Lixisenatide Is Effective and Well Tolerated in Patients with Type 2 Diabetes Mellitus and Renal Impairment
    Gomez-Huelgas, Ricardo
    Ambos, Anu
    Arteaga, Juan M.
    Leiter, Lawrence A.
    Marchesini, Giulio
    Nikonova, Elena
    Shestakova, Marina
    Stager, William
    Tambascia, Marcos
    Hanefeld, Markolf
    DIABETES, 2014, 63 : A254 - A255
  • [7] Glimepiride is effective and well tolerated in patients with Type 2 diabetes during Ramadhan fasting
    Ben Khalifa, F
    DIABETES, 2002, 51 : A483 - A484
  • [8] Rosiglitazone monotherapy is effective in patients with type 2 diabetes
    Lebovitz, HE
    Dole, JF
    Patwardhan, R
    Rappaport, EB
    Freed, MI
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01): : 280 - 288
  • [9] Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes
    Rosak, C
    Petzoldt, R
    Wolf, R
    Reblin, T
    Dehmel, B
    Seidel, D
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (10) : 1131 - 1136
  • [10] Repaglinide is well tolerated and effective in Type 2 diabetes complicated by renal impairment
    Koselj, M
    Gali, M
    Sieber, J
    Dieken, ML
    Hasslacher, C
    DIABETOLOGIA, 2001, 44 : A36 - A36
12345